Johnson & Johnson

Yahoo Finance • 21 hours ago

Needham upgrades Boston Scientific on easing competition, growth opportunities

Investing.com -- Needham upgraded Boston Scientific Corp (NYSE:BSX) to “Buy”, saying competition from pulsed field ablation (PFA) rivals looks less intense for its key product than it was earlier feared, and citing near- and long-term upsi... Full story

Yahoo Finance • 21 hours ago

Is Johnson & Johnson (JNJ) the Best Dividend Monarch to Invest in Now?

We recently published a list of the 10 Best Dividend Monarchs to Invest in Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best dividend monarchs. Dividend-focused investors are... Full story

Yahoo Finance • 23 hours ago

Jim Cramer: Johnson & Johnson (JNJ) Is a “Great American Company with a AAA Balance Sheet”

We recently published a list of Jim Cramer Sounds the Alarm on China Rhetoric and Dollar Panic Then Analyzes 11 Key Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other key stocks... Full story

Yahoo Finance • 2 days ago

Johnson & Johnson Q1 Earnings: Strong Cancer Drug Sales, Boosts Quarterly Dividend, Anticipates Negative Currency Impact For 2025 Profit

Johnson & Johnson (NYSE:JNJ), on Tuesday, reported a first-quarter 2025 adjusted EPS of $2.77, up 2.2% year over year, beating the consensus of $2.60. The pharmaceutical giant reported sales of $21.89 billion, up 2.4% year over year and b... Full story

Yahoo Finance • 4 days ago

Why Johnson & Johnson (JNJ) is the Best Medical Stock to Buy According to Billionaires

We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best medical stocks to buy according to billio... Full story

Yahoo Finance • 5 days ago

Is Johnson & Johnson (NYSE:JNJ) a Cheap NYSE Stock to Invest in According to Hedge Funds?

We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other cheap NYSE stocks. On March 26, Jack C... Full story

Yahoo Finance • 6 days ago

Jim Cramer on Johnson & Johnson (JNJ): AAA Balance Sheet… An Unjustified Casualty of Pharma Tariffs

We recently published a list of Jim Cramer Questions Market Logic and Dissects These 7 Key Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other stocks that Jim Cramer discusses. I... Full story

Yahoo Finance • 8 days ago

Johnson & Johnson (NYSE:JNJ) Shares React as FDA Grants Multiple Designations to Nipocalimab

Johnson & Johnson announced compelling results from its Phase 3 Vivacity-MG3 study on nipocalimab, showing promising efficacy and safety in treating generalized myasthenia gravis, which were significant events during the quarter. Additiona... Full story

Yahoo Finance • 9 days ago

Johnson & Johnson (JNJ): Among Defensive Stocks Billionaire Ken Fisher is Betting On

We recently published a list of 10 Defensive Stocks Billionaire Ken Fisher is Betting On. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other defensive stocks billionaire Ken Fisher is be... Full story

Yahoo Finance • 13 days ago

Johnson & Johnson's Tremfya Shows Efficacy In Late-Stage Psoriatic Arthritis Study

Johnson & Johnson (NYSE:JNJ) on Friday announced topline results from Phase 3b APEX study of Tremfya (guselkumab) in patients with active psoriatic arthritis (PsA) who are biologic naïve and have had an inadequate response to standard ther... Full story

Yahoo Finance • 14 days ago

Man With $30K To Deploy Wants Dividends For Life – 'Even If It's Just Enough To Pay For A Yearly Vacation Here Or There,' Reddit Reacts

For many investors, dividend-focused stocks and funds provide a way to generate passive income, whether to supplement retirement, cover day-to-day expenses, or even finance small luxuries like annual vacations. While some aim for signific... Full story

Yahoo Finance • 15 days ago

What's next for Johnson and Johnson after third failed attempt to settle talc laws

Investing.com -- U.S. Bankruptcy Court Judge Christopher Lopez in the Southern District of Texas rejected a request from Johnson & Johnson's (NYSE:JNJ) subsidiary, Red River Talc, to approve its prepackaged bankruptcy plan. In his decisio... Full story

Yahoo Finance • 16 days ago

Johnson & Johnson (JNJ): Among the Best Healthcare Stocks to Buy According to Billionaires

We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best healthcare stocks to invest in. Healt... Full story

Yahoo Finance • 16 days ago

J&J stock drops after failed attempt to end talc claims

Investing.com -- A U.S. bankruptcy judge has dismissed Johnson & Johnson’s third attempt to resolve its widespread talc-related lawsuits through Chapter 11, marking another setback in the company’s efforts to end the litigation. Judge Chr... Full story

Yahoo Finance • 16 days ago

Trending tickers: Tesla, Moderna, Newsmax, Johnson & Johnson and Travis Perkins

Tesla (TSLA) Fresh sales data on Tuesday showed continued poor performance for electric vehicle maker Tesla (TSLA) in Europe, amid backlash against CEO Elon Musk's political activities. Official data showed that Tesla (TSLA) registered 3... Full story

Yahoo Finance • 16 days ago

J&J shares fall after judge rejects $10 billion talc settlement

(Reuters) -Johnson & Johnson shares fell more than 3% on Tuesday after a U.S. bankruptcy judge rejected its $10 billion proposal to end tens of thousands of lawsuits alleging that its baby powder and other talc products cause ovarian cance... Full story

Yahoo Finance • 17 days ago

Johnson & Johnson (JNJ): Among the Best Dividend Aristocrat Stocks with Over 3% Yield

We recently published a list of the 15 Best Dividend Aristocrat Stocks with Over 3% Yield. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best dividend aristocrats with a high yield.... Full story

Yahoo Finance • 17 days ago

1 Healthcare Stock to Target This Week and 2 to Turn Down

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past si... Full story

Yahoo Finance • 19 days ago

Jim Cramer on Johnson & Johnson (NYSE:JNJ): Their Spinoff Was Ill-Advised

We recently published a list of Jim Cramer Says Trump’s Tariff Strategy Is Working & Discusses These 11 Stocks. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other stocks that Jim Cramer... Full story

Yahoo Finance • 23 days ago

Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan

WARREN, N.J., March 25, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company leveraging AI-driven immunotherapy drug discovery, today ann... Full story